Average Co-Inventor Count = 10.72
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (16 from 169 patents)
2. Celgene Corporation (2 from 550 patents)
18 patents:
1. 12486281 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
2. 11306101 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
3. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
4. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
5. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
6. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
7. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
8. 9079900 - Methods of synthesis and purification of heteroaryl compounds
9. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
10. 8569494 - Methods of synthesis and purification of heteroaryl compounds
11. 8507492 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
12. 8492381 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
13. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds
14. 8110578 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
15. 7981893 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith